Human granulocyte-colony stimulating factor isoforms
AssigneeCj Cheiljedang Corporation
InventorHyung Kon Koh
Life of this patent
Estimating the term…
Loading patent…
AssigneeCj Cheiljedang Corporation
InventorHyung Kon Koh
Estimating the term…
Disclosed is a novel physiologically active protein, which is a human granulocyte colony stimulating factor isoform, constructed in order to increase the in vivo lifetime of human granulocyte colony sedtimulating factor. The human granulocyte colony stimulating factor isoform comprises a polypeptide and polyethylene glycol (PEG) bound thereto as a non-protein polymer. A specific site of the polypeptide is selected so that polyethylene can be bound to the site while not adversely affecting the activity of the protein. The amino acid of the site is modified with cysteine and polyethylene glycol is bound to the modified site. A pharmaceutical composition comprising the isoforms, genes encoding the isoforms, and a primer for modifying the amino acid sequence are also disclosed.
A granulocyte colony stimulating factor isoform, which includes at least one amino acid added before Thr of N-terminal or after Pro of C-terminal in human granulocyte colony stimulating factor represented by amino acid Sequence No. 1, wherein at least one of the added amino acids is cysteine, and polyethylene glycol is bound to at least one of the added cysteine.
Dependencies are inferred from the claim text.